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Filling in the gap: cloning a connexin
 
ow do you construct a channel between cells
 
?
 
 The
first step in answering this question was to isolate the
components of one type of channel—the gap junction. H
 
Daniel Goodenough had been pur-
suing gap junction proteins since
his days as a graduate student in
the mid-1960s with Jean-Paul Revel,
who helped discover the structures
(Revel and Karnovsky, 1967; see “Defining gap junctions”
 
JCB
 
 169:379). In 1972, Goodenough demonstrated that gap
junctions could be purified biochemically (Goodenough and
Stoeckenius, 1972). By the mid-1970s, when Goodenough
had his own lab at Harvard Medical School (Boston, MA),
the field was struggling with spotty antibodies in its efforts to
identify which proteins were forming the junctions.
When then graduate student David Paul joined Good-
enough, they strove to make a clean enough preparation of
rat liver gap junctions to generate a better antibody—hopefully
one that could be used for expression cloning. Paul says
there was nothing “technically miraculous” about their approach,
An anticonnexin antibody stained only junctional plasma membranes.
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but it was the right time to clone the 1.5 Kb cDNA of a 32-kD
gap junction protein (Paul, 1986).
Norton “Bernie” Gilula’s lab cloned the same rat liver
connexin, now known as connexin
32 (Cx32), the same year (Kumar
and Gilula, 1986). This group used
an oligonucleotide probe based on a
partial protein sequence to pull out
cDNAs for the human and then rat liver proteins.
Paul admits that being the first to work with DNA in
Goodenough’s lab was “scary,” but his molecular leap paid
off. Northern blots revealed three related mRNAs—one in
liver, brain, kidney, and stomach tissues, and others in heart
and lens. That prompted the lab to formally name the family
of related proteins as connexins and to clone the genes en-
coding a heart gap junction protein, Cx43 (Beyer et al.,
1987), and a lens gap junction protein, Cx46 (Paul et al.,
1991). “Everyone was struggling with the antibodies,”
Goodenough recalls, but the cDNAs moved things forward.
The cDNAs also allowed expression experiments in cells
that did not normally make gap junctions, thus
demonstrating that the proteins could form
channels that allowed communication (Dahl et
al., 1987). Later studies turned up the se-
quence-unrelated innexins (invertebrate con-
nexins), the mammalian pannexins (a group
more ancient than mammalian connexins), and
the insect virus vinnexins.
Connexins were also linked to disease.
Cx26 mutations account for about half of all
cases of genetic deafness, Cx46 and Cx50
mutations cause familial cataracts, and Cx32
mutations are a common cause of the peripheral
nerve disorder Charcot-Marie-Tooth disease
(Bergoffen et al., 1993). 
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David Paul, Daniel Goodenough, 
Nalin Kumar, and Norton Gilula 
clone the first connexin proteins.
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